Sponsored
Sponsored
Media Summary: The increasing popularity of GLP-1 weight-loss drugs has driven drugmaker The GLP-1 drug revolution has taken the medicine world by storm. I've done several episodes on the science of GLP-1s.

Eli Lilly Ceo We Expect - Detailed Analysis & Overview

The increasing popularity of GLP-1 weight-loss drugs has driven drugmaker The GLP-1 drug revolution has taken the medicine world by storm. I've done several episodes on the science of GLP-1s.

Photo Gallery

Eli Lilly CEO David Ricks on Q3 results: The underlying growth story is fantastic
Eli Lilly CEO: Our pill supply can 'reach the planet'
Eli Lilly CEO: We expect to launch five new medicines in 2022
Eli Lilly CEO: We know there's high demand for weight-loss drugs and we're ready to meet it
Eli Lilly CEO David Ricks on $1T market value, obesity pill launch and drug pipeline outlook
Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing
Eli Lilly CEO: We see a path to an Alzheimer's disease-modifying drug
Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharma
Eli Lilly CEO on raising $1B for antibiotic research: Goal is to have two to four new antibiotics
Eli Lilly CEO on Fighting Obesity, Developing New Drugs
Eli Lilly CEO David Ricks on 3-year obesity drug study: This is a profound result
Eli Lilly CEO on Fighting Cancer and Obesity, Drug Pricing
View Detailed Profile
Eli Lilly CEO David Ricks on Q3 results: The underlying growth story is fantastic

Eli Lilly CEO David Ricks on Q3 results: The underlying growth story is fantastic

Eli Lilly CEO

Eli Lilly CEO: Our pill supply can 'reach the planet'

Eli Lilly CEO: Our pill supply can 'reach the planet'

Eli Lilly

Sponsored
Eli Lilly CEO: We expect to launch five new medicines in 2022

Eli Lilly CEO: We expect to launch five new medicines in 2022

Eli Lilly CEO

Eli Lilly CEO: We know there's high demand for weight-loss drugs and we're ready to meet it

Eli Lilly CEO: We know there's high demand for weight-loss drugs and we're ready to meet it

David Ricks,

Eli Lilly CEO David Ricks on $1T market value, obesity pill launch and drug pipeline outlook

Eli Lilly CEO David Ricks on $1T market value, obesity pill launch and drug pipeline outlook

Eli Lilly

Sponsored
Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing

Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing

(0:00) Introducing

Eli Lilly CEO: We see a path to an Alzheimer's disease-modifying drug

Eli Lilly CEO: We see a path to an Alzheimer's disease-modifying drug

Eli Lilly CEO

Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharma

Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharma

Dave Ricks, the

Eli Lilly CEO on raising $1B for antibiotic research: Goal is to have two to four new antibiotics

Eli Lilly CEO on raising $1B for antibiotic research: Goal is to have two to four new antibiotics

Eli Lilly CEO

Eli Lilly CEO on Fighting Obesity, Developing New Drugs

Eli Lilly CEO on Fighting Obesity, Developing New Drugs

Eli Lilly

Eli Lilly CEO David Ricks on 3-year obesity drug study: This is a profound result

Eli Lilly CEO David Ricks on 3-year obesity drug study: This is a profound result

CNBC's Angelica Peebles and

Eli Lilly CEO on Fighting Cancer and Obesity, Drug Pricing

Eli Lilly CEO on Fighting Cancer and Obesity, Drug Pricing

Eli Lilly

AI and GLP-1 drugs: Eli Lilly & Co.'s CEO talks of focus beyond 150 years

AI and GLP-1 drugs: Eli Lilly & Co.'s CEO talks of focus beyond 150 years

Eli Lilly

Eli Lilly CEO on weight loss drugs outlook: Our top priority is making more product

Eli Lilly CEO on weight loss drugs outlook: Our top priority is making more product

Eli Lilly CEO

Eli Lilly CEO Dave Ricks on revolutionizing healthcare and medicine

Eli Lilly CEO Dave Ricks on revolutionizing healthcare and medicine

The increasing popularity of GLP-1 weight-loss drugs has driven drugmaker

Eli Lilly CEO talks deal to cut medication prices with the Trump administration

Eli Lilly CEO talks deal to cut medication prices with the Trump administration

NBC News' Tom Llamas talks to

The Future of GLP-1 Drugs and AI Medicine, With Eli Lilly CEO David Ricks | Plain English

The Future of GLP-1 Drugs and AI Medicine, With Eli Lilly CEO David Ricks | Plain English

The GLP-1 drug revolution has taken the medicine world by storm. I've done several episodes on the science of GLP-1s.

Eli Lilly CEO: The price of medicines needs to be kept in perspective

Eli Lilly CEO: The price of medicines needs to be kept in perspective

Eli Lilly CEO

Eli Lilly CEO Reiterates 5% Revenue Growth Target

Eli Lilly CEO Reiterates 5% Revenue Growth Target

Jul.25 -- Dave Ricks, chief

Eli Lilly CEO David Ricks on positive Alzheimer's drug trial data

Eli Lilly CEO David Ricks on positive Alzheimer's drug trial data

Eli Lilly CEO

Related Video Content

Eli (2019 film) - Wikipedia information

Eli is a 2019 American supernatural horror film directed by Ciarán Foy from a screenplay by David Chirchirillo, Ian...

Eli (2019) - IMDb information

Eli: Directed by Ciarán Foy. With Charlie Shotwell, Kelly Reilly, Max Martini, Lili Taylor. A boy receiving treatment...

Watch Eli | Netflix Official Site information

With his desperate parents in tow, an 11-year-old boy with a debilitating illness checks into an isolated clinic to...

Eli | Official Trailer | Netflix - YouTube information

Oct 3, 2019 · As a last resort to cure their son’s auto-immune disorder, the Millers move into a sterile manor during...

Who was Eli in the Bible? - GotQuestions.org information

Jan 4, 2022 · Eli in the Bible was a Jewish priest living in the days of the judges and serving God at the tabernacle...

Sponsored